Matches in Nanopublications for { ?s ?p "[The risk for progression of endometrial hyperplasia to atypical hyperplasia and eventually endometrioid adenocarcinoma may be accompanied by an increase in the number of alternative splicing variants of mRNA ER-alpha.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 11 of
11
with 100 items per page.
- NP616022.RAQ9PjsFfCxv1cBautNHCbufIyruHkBIRspOAuTs0Jrpc130_assertion description "[The risk for progression of endometrial hyperplasia to atypical hyperplasia and eventually endometrioid adenocarcinoma may be accompanied by an increase in the number of alternative splicing variants of mRNA ER-alpha.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP616022.RAQ9PjsFfCxv1cBautNHCbufIyruHkBIRspOAuTs0Jrpc130_provenance.
- assertion description "[The risk for progression of endometrial hyperplasia to atypical hyperplasia and eventually endometrioid adenocarcinoma may be accompanied by an increase in the number of alternative splicing variants of mRNA ER-alpha.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The risk for progression of endometrial hyperplasia to atypical hyperplasia and eventually endometrioid adenocarcinoma may be accompanied by an increase in the number of alternative splicing variants of mRNA ER-alpha.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The risk for progression of endometrial hyperplasia to atypical hyperplasia and eventually endometrioid adenocarcinoma may be accompanied by an increase in the number of alternative splicing variants of mRNA ER-alpha.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP384362.RAYZ3pqJovGG_NNxG1NAUmNU-jxjiJJNgC5kKPTBuGZY0130_assertion description "[The risk for progression of endometrial hyperplasia to atypical hyperplasia and eventually endometrioid adenocarcinoma may be accompanied by an increase in the number of alternative splicing variants of mRNA ER-alpha.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP384362.RAYZ3pqJovGG_NNxG1NAUmNU-jxjiJJNgC5kKPTBuGZY0130_provenance.
- NP384999.RASzK5TYmR6V6HtOOJfSNJf1l5DFHyqBtLd1JjZsBc2z0130_assertion description "[The risk for progression of endometrial hyperplasia to atypical hyperplasia and eventually endometrioid adenocarcinoma may be accompanied by an increase in the number of alternative splicing variants of mRNA ER-alpha.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP384999.RASzK5TYmR6V6HtOOJfSNJf1l5DFHyqBtLd1JjZsBc2z0130_provenance.
- NP752693.RAMOZCBnk-5d9-z34EPIqq2h4upyK7aKWijCNjNEZdziA130_assertion description "[The risk for progression of endometrial hyperplasia to atypical hyperplasia and eventually endometrioid adenocarcinoma may be accompanied by an increase in the number of alternative splicing variants of mRNA ER-alpha.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP752693.RAMOZCBnk-5d9-z34EPIqq2h4upyK7aKWijCNjNEZdziA130_provenance.
- NP614526.RAUMfWjyhOoHo3cCwqwcI3jI5AxwXBI3BmKRfhvs0ou8k130_assertion description "[The risk for progression of endometrial hyperplasia to atypical hyperplasia and eventually endometrioid adenocarcinoma may be accompanied by an increase in the number of alternative splicing variants of mRNA ER-alpha.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP614526.RAUMfWjyhOoHo3cCwqwcI3jI5AxwXBI3BmKRfhvs0ou8k130_provenance.
- NP614527.RAR5-vBsWPeRdyhbCyCjl57UhNt219SsCz4rATTfl8fPY130_assertion description "[The risk for progression of endometrial hyperplasia to atypical hyperplasia and eventually endometrioid adenocarcinoma may be accompanied by an increase in the number of alternative splicing variants of mRNA ER-alpha.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP614527.RAR5-vBsWPeRdyhbCyCjl57UhNt219SsCz4rATTfl8fPY130_provenance.
- NP383822.RAF4chCxevtBmTdtHCA18MIH9UDjKgg7XLzxDEEKurK_M130_assertion description "[The risk for progression of endometrial hyperplasia to atypical hyperplasia and eventually endometrioid adenocarcinoma may be accompanied by an increase in the number of alternative splicing variants of mRNA ER-alpha.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP383822.RAF4chCxevtBmTdtHCA18MIH9UDjKgg7XLzxDEEKurK_M130_provenance.
- NP614529.RA1NosNxLjxFIEhA71fYvA42Nts4wNeeBxJ8z3YxKIlck130_assertion description "[The risk for progression of endometrial hyperplasia to atypical hyperplasia and eventually endometrioid adenocarcinoma may be accompanied by an increase in the number of alternative splicing variants of mRNA ER-alpha.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP614529.RA1NosNxLjxFIEhA71fYvA42Nts4wNeeBxJ8z3YxKIlck130_provenance.